BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Eisai and Bial partner for European commercialization of Zebinix
Feb. 20, 2009
sanofi-aventis imparts new cannabinoid CB2 receptor antagonists for pain relief
Feb. 20, 2009
New gamma-secretase inhibitors reported in recent Schering-Plough patent
Feb. 20, 2009
AVI BioPharma treats first patient in AVI-4658 Duchenne muscular dystrophy trial
Feb. 20, 2009
TRPV1-mediated analgesic activity is enhanced by repeated administration of ABT-102
Feb. 20, 2009
FDA extends Hemispherx's NDA review date for Ampligen in CFS
Feb. 19, 2009
FDA sets PDUFA date for review of Zogenix's NDA for migraine drug Sumavel DosePro
Feb. 19, 2009
Phase III SOFIA study does not achieve primary endpoint in autistic disorder
Feb. 19, 2009
Pharmos agrees to sell PRS-639058 and other CB2 agonists to Reperio
Feb. 19, 2009
Cipher receives tentative FDA approval for extended-release tramadol
Feb. 18, 2009
Previous
1
2
…
1450
1451
1452
1453
1454
1455
1456
1457
1458
…
2796
2797
Next
RSS